Clinical Trials Directory

Trials / Completed

CompletedNCT04777929

The Relationship of Phthalate Exposure During Pregnancy and Preeclampsia

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Second Affiliated Hospital of Wenzhou Medical University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Phthalates are a group of ubiquitous synthetic endocrine-disrupting chemicals. Fetal and neonatal periods are particularly susceptible to endocrine disorders, which prenatal exposure to phthalates causes. There is increasing evidence concerning the potential endocrine disrupting for phthalate exposure during pregnancy. Prenatal exposure phthalates would disrupt the level of sex hormone in pregnant women, which results in preeclampsia. The relationship of prenatal phthalate exposure with maternal and neonatal outcomes in human beings was often sex-specific associations. Because of the potentially harmful influence of prenatal phthalate exposure, steps should be taken to prevent or reduce phthalate exposure during pregnancy.

Conditions

Interventions

TypeNameDescription
OTHERtest Phthalates, estrogen and progesteronetest mothers Phthalates in their urine, and test estrogen and progesterone receptor in placental tissue

Timeline

Start date
2021-01-01
Primary completion
2022-09-30
Completion
2022-10-31
First posted
2021-03-02
Last updated
2022-11-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04777929. Inclusion in this directory is not an endorsement.